Orthofix Medical price to free cash flow OFIX

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 45.7×; Feb 2022
10-year median: 26.8×
10-year range: 14.2× to 70.6×
Peer median: 16.7×

Orthofix Medical's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Feb 2022, at 45.7×.

On the days it had one over the last ten years, its median was 26.8×, from 14.2× in Apr 2021 to 70.6× in Jan 2018.

Price to free cash flow over time

median 26.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2022	45.7×	43.3×	47.9×
2021	45.2×	14.2×	52.5×
2020	17.7×	14.5×	52.0×
2019	37.4×	20.7×	37.7×
2018	21.7×	20.3×	70.6×
2017	67.1×	17.4×	67.8×
2016	17.8×	17.0×	59.6×
2015	54.9×	12.0×	57.9×
2014	29.6×	13.0×	35.1×
2013	10.6×	10.6×	11.1×
2012	11.1×	10.0×	11.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest Orthofix Medical's size, closest first, today.

Company	Price to free cash flow
OFIXOrthofix Medical	n/m
EMBCEmbecta	2.3×
TCMDTactile Systems Technology	20.0×
MDXGMimedx	n/m
INFUInfuSystem	12.1×
UTMDUtah Medical Products	20.6×
MOVMovado	9.8×
PDEXPro DEX	29.5×
IRMDIradimed	43.7×
STAAStaar Surgical	n/m
BVSBioventus	13.3×
Peer median	16.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Orthofix Medical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.